| Literature DB >> 32990676 |
Line S Reinert1, Ahmad S Rashidi1,2, Diana N Tran2, Georgios Katzilieris-Petras1, Astrid K Hvidt1, Mette Gohr1, Stefanie Fruhwürth3, Chiranjeevi Bodda1, Martin K Thomsen1, Mikkel H Vendelbo1,4, Ahmad R Khan5,6, Brian Hansen5, Petra Bergström7, Lotta Agholme7, Trine H Mogensen1, Maria H Christensen8, Jens R Nyengaard9, Ganes C Sen10, Henrik Zetterberg3,11,12, Georges Mgm Verjans2, Søren R Paludan1,3.
Abstract
Protection of the brain from viral infections involves the type I IFN (IFN-I) system, defects in which render humans susceptible to herpes simplex encephalitis (HSE). However, excessive cerebral IFN-I levels lead to pathologies, suggesting the need for tight regulation of responses. Based on data from mouse models, human HSE cases, and primary cell culture systems, we showed that microglia and other immune cells undergo apoptosis in the HSV-1-infected brain through a mechanism dependent on the cyclic GMP-AMP synthase/stimulator of interferon genes (cGAS/STING) pathway, but independent of IFN-I. HSV-1 infection of microglia induced cGAS-dependent apoptosis at high viral doses, whereas lower viral doses led to IFN-I responses. Importantly, inhibition of caspase activity prevented microglial cell death and augmented IFN-I responses. Accordingly, HSV-1-infected organotypic brain slices or mice treated with a caspase inhibitor exhibited lower viral load and an improved infection outcome. Collectively, we identify an activation-induced apoptosis program in brain immune cells that downmodulates local immune responses.Entities:
Keywords: Apoptosis pathways; Immunology; Infectious disease; Innate immunity; Neurological disorders
Mesh:
Substances:
Year: 2021 PMID: 32990676 PMCID: PMC7773356 DOI: 10.1172/JCI136824
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 19.456